STOCK TITAN

Vicarious Surgical Inc. - RBOT STOCK NEWS

Welcome to our dedicated page for Vicarious Surgical news (Ticker: RBOT), a resource for investors and traders seeking the latest updates and insights on Vicarious Surgical stock.

Vicarious Surgical Inc. (symbol: RBOT) is at the forefront of innovation in the field of surgical robotics. The company is dedicated to enhancing the capabilities of surgeons and improving patient outcomes through advanced technological solutions. Vicarious Surgical has developed a unique surgical robot that combines human-like dexterity with the world's first virtual-reality surgical camera, enabling surgeons to perform minimally invasive procedures with the same ease as traditional open surgery.

The company’s flagship product, the Vicarious Surgical Robotic System, is specifically designed for abdominal surgeries. It offers 3D visualization and precise control, all through a single port, which significantly reduces the invasiveness of surgical procedures. This groundbreaking technology aims to expand global access to high-quality surgical care.

Vicarious Surgical's approach redefines what is possible in surgical robotics by integrating cutting-edge virtual reality and robotics technology. The company has achieved significant milestones in recent years, including key partnerships and notable advancements in their robotic systems.

Financially, Vicarious Surgical continues to show promise with robust investments and strategic collaborations that drive its growth and innovation. The company remains committed to pushing the boundaries of medical technology, with ongoing projects focused on further enhancing their systems and expanding their applications.

For investors and stakeholders, Vicarious Surgical represents a compelling opportunity in the rapidly evolving field of medical technology. The company’s mission to improve surgical outcomes and patient care through revolutionary robotics sets it apart as a leader in the industry.

Stay updated with the latest news and developments from Vicarious Surgical to understand its impact and progress in the surgical robotics landscape.

Rhea-AI Summary
Vicarious Surgical Inc. (RBOT) announced the pricing of its underwritten public offering of 45,000,000 shares of its Class A common stock at $1.00 per share, with an option to purchase up to an additional 6,750,000 shares. The Company expects to receive total gross proceeds of approximately $45.0 million from the offering.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-41.52%
Tags
-
Rhea-AI Summary
Vicarious Surgical Inc. (RBOT) has announced a public offering of $45.0 million of its Class A common stock, with an option for underwriters to purchase up to $6.75 million of additional shares. The company intends to use the proceeds for ongoing operations and the development of its single-port surgical robot, the Vicarious Surgical System.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-41.52%
Tags
-
Rhea-AI Summary
Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) announces Q2 2023 financial results, FDA clarity, and hospital system agreement. The company expects to complete the first ventral hernia procedure in a patient mid-2024. Operating expenses increased by 12% compared to the prior year. The company had $82.8 million in cash, cash equivalents, and short-term investments as of June 30, 2023, representing a quarterly cash burn of $14.9 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.75%
Tags
Rhea-AI Summary
Vicarious Surgical Inc. will report financial results for Q2 2023 on July 27, 2023. A conference call will be held at 4:30 p.m. ET. Webcast available at https://investor.vicarioussurgical.com.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.14%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.47%
Tags
management
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.48%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.33%
Tags
none
-
Rhea-AI Summary

Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) announced it will release its financial results for the first quarter ended March 31, 2023, on May 8, 2023, after market close. The company will host a conference call at 4:30 p.m. Eastern Time to discuss these results. Vicarious Surgical is focused on advanced surgical robotics with the aim of enhancing surgical efficiency, improving patient outcomes, and reducing healthcare costs. Backed by prominent investors, including Bill Gates and Khosla Ventures, the company is known for its innovative approach that transports surgeons inside patients for minimally invasive surgeries. Stakeholders can access further information via the company's investor website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.2%
Tags
conferences earnings
-
Rhea-AI Summary

Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) has announced its participation in two upcoming investor conferences. The company aims to enhance surgical procedures through innovative robotics technology.

The first event is the Cowen 43rd Annual Healthcare Conference, featuring a fireside chat on March 8th at 9:50 a.m. ET. The second is the Oppenheimer 33rd Annual Healthcare Conference, with a virtual presentation scheduled for March 14th at 1:20 p.m. ET. Live and archived versions of these presentations will be available on the company's website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.91%
Tags
conferences
Rhea-AI Summary

Vicarious Surgical reported a cash burn of $67 million for 2022, meeting its objective, and announced initiatives to extend its cash runway. The company expects 2023 cash burn between $55-$65 million. Vicarious Surgical's operating expenses surged to $80.1 million in 2022 versus $38.2 million in 2021, with an adjusted net loss of $78.8 million, or $0.65 per share. Despite a GAAP net income of $5.2 million for the year, the company reported significant losses. Notable achievements include the completion of the Beta 2 robotic system and partnerships with major healthcare providers, enhancing its market position.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.64%
Tags

FAQ

What is the current stock price of Vicarious Surgical (RBOT)?

The current stock price of Vicarious Surgical (RBOT) is $9.36 as of November 15, 2024.

What is the market cap of Vicarious Surgical (RBOT)?

The market cap of Vicarious Surgical (RBOT) is approximately 57.8M.

What does Vicarious Surgical Inc. specialize in?

Vicarious Surgical Inc. specializes in surgical robotics, developing systems that enhance surgical precision and reduce invasiveness.

What is the Vicarious Surgical Robotic System?

The Vicarious Surgical Robotic System is a state-of-the-art surgical robot designed for minimally invasive abdominal surgery, featuring 3D visualization and precise control.

How does Vicarious Surgical's technology benefit surgeons?

The technology allows surgeons to perform minimally invasive surgery with the ease and precision of open surgery, enhancing their capabilities through advanced 3D visualization and control.

What makes Vicarious Surgical's approach unique?

Vicarious Surgical combines human-like robotic dexterity with virtual reality technology, setting them apart in the field of surgical robotics.

Where can I find the latest news about Vicarious Surgical Inc.?

You can find the latest news about Vicarious Surgical Inc. on their official website, stock market websites like StockTitan, and through financial news outlets.

What are the recent achievements of Vicarious Surgical Inc.?

Recent achievements include advancements in their robotic systems, strategic partnerships, and key developments in their technology and business operations.

How does the Vicarious Surgical Robotic System improve patient outcomes?

The system reduces the invasiveness of procedures, which can lead to faster recovery times and fewer complications, improving overall patient outcomes.

Is Vicarious Surgical Inc. involved in any partnerships?

Yes, Vicarious Surgical has formed strategic partnerships to enhance their technology and expand their market reach.

What is the focus area of Vicarious Surgical's robotic system?

The primary focus area of Vicarious Surgical's robotic system is abdominal surgery, providing exceptional access and visualization through a single port.

How does Vicarious Surgical's technology expand global access to surgical care?

By enabling minimally invasive procedures with advanced technology, Vicarious Surgical's systems make high-quality surgical care more accessible worldwide.

Vicarious Surgical Inc.

NYSE:RBOT

RBOT Rankings

RBOT Stock Data

57.82M
5.24M
26.62%
35.94%
1.57%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States of America
WALTHAM